The state of the fight:A U.S. regulatory committee endorsed booster doses for vulnerable people and those over age 65.
Kenya outlined plans to start fill-finish production of Covid-19 shots in early 2022.
An SII subsidiary scooped up a 15% stake in Biocon’s biologics unit as the companies launched a strategic alliance to produce and commercialize vaccines. Approved or authorized vaccines
A new substudy in The Lancet supports flexible schedules for the…